On 31 March 2026, the Australian Prudential Regulation Authority (APRA) issued its response paper finalising amendments to the capital treatment for longevity products.
Background
The response document follows two rounds of consultation that took place in June 2025 and October 2025.
The response document includes an attachment which summarises the key changes to